An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy
Nanoparticles (NPs) are promising drug delivery systems (DDS) for identifying and treating cancer. Active targeting NPs can be generated by conjugation with ligands that bind overexpressed or mutant cell surface receptors on target cells that are poorly or not even expressed on normal cells. Recepto...
Main Authors: | Alberto Juan, Francisco J. Cimas, Iván Bravo, Atanasio Pandiella, Alberto Ocaña, Carlos Alonso-Moreno |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/9/802 |
Similar Items
-
Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment
by: Alberto Juan, et al.
Published: (2020-08-01) -
Toward Homogenous Antibody Drug Conjugates Using Enzyme-Based Conjugation Approaches
by: Ahmad Fawzi Hussain, et al.
Published: (2021-04-01) -
Antibody Drug Conjugates for Cancer Therapy
by: S M Gheibi hayat, et al.
Published: (2017-07-01) -
Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
by: Jakub Radocha, et al.
Published: (2021-03-01) -
Antibody–Drug Conjugates for the Treatment of Breast Cancer
by: Chiara Corti, et al.
Published: (2021-06-01)